Repurposed malaria drug hits leukemia’s metabolic weak spot

Artesunate-arsenic combo targets energy pathways and overcomes drug resistance in acute myeloid leukemia. Artesunate-arsenic combo targets energy pathways and overcomes drug resistance in acute myeloid leukemia.

Publication Details

Journal
Nature India
Published
2025-11-12
DOI
https://doi.org/10.1038/d44151-025-00205-z
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Repurposed malaria drug hits leukemia’s metabolic weak spot

Nature India
Acute Myeloid Leukemia Research
article

Repurposed malaria drug hits leukemia’s metabolic weak spot

article en

Abstract

Artesunate-arsenic combo targets energy pathways and overcomes drug resistance in acute myeloid leukemia. Artesunate-arsenic combo targets energy pathways and overcomes drug resistance in acute myeloid leukemia.

Nature India
Openalex Percentile: Top 56%
Acute Myeloid Leukemia Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Repurposed malaria drug hits leukemia’s metabolic weak spot · Nature India (2025) | TGRS Research Map | TGRS